Repeat Subcutaneous Dosing of Exendin 9-39 Reduces Hyperinsulinemic Hypoglycemia and Neuroglycopenic Symptoms in Patients with Post-Bariatric Hypoglycemia American Diabetes Association 77th Scientific Sessions Tan, M., Luong, R., Lamendola, C., Liu, L., Craig, C.